Merrimack Pharmaceuticals, Inc. (MACK) Research

Founded in 1993, Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cambridge, Massachusetts.

Market snapshot

Symbol
MACK
Price
$15.15
Day change
+0.10%
Market cap
$224.0M
P/E ratio
-183.37x
52-week range
11.53-15.89
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Catabasis Pharmaceuticals, Inc. (CATB)
  • Cytocom, Inc. (CBLI)
  • CARGO Therapeutics, Inc. Common Stock (CRGX)
  • Inhibrx Biosciences, Inc. (INXB)
  • Acelyrin, Inc. (SLRN)
  • Spectrum Pharmaceuticals, Inc. (SPPI)
  • Alaunos Therapeutics, Inc. (TCRT)
  • Third Harmonic Bio, Inc. (THRD)

Recent insider activity

  • Andersen Eric — P-Purchase (857 shares) on 2023-12-28
  • Andersen Eric — P-Purchase (48693 shares) on 2023-12-26
  • Andersen Eric — P-Purchase (76384 shares) on 2023-12-07
  • Andersen Eric — P-Purchase (24666 shares) on 2023-12-07
  • Andersen Eric — P-Purchase (235 shares) on 2023-11-17

Open Merrimack Pharmaceuticals, Inc. (MACK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.